Gustavo Barisone, PhD
Phase I/II Trial of FWGP in Patients with NHL Receiving Rituximab Therapy

Jenna Burton, DVM, MS, DACVIM
Contributions of B-cell Lymphoma Microenvironment in the Development of Drug Resistance

Luis Carvajal-Carmona, BSc, PhD
Colorectal Cancer Gene Discovery in Hispanics through Whole Genome Sequencing

Megan Daly, MD
Extending the Benefit of Immunotherapy for Metastatic Non-Small Cell Lung Cancer with Ablative Radiation

Brian Jonas, MD, PhD
A Daunorubicin and Cytarabine Microdosing Feasibility Study in Adult Acute Myeloid Leukemia

Maija Kiuru, MD, PhD
Molecular Subtyping of Nevi and Melanoma to Improve Diagnostic Accuracy and Identify Drivers of Melanomagenesis

Robert Canter, MD, MAS, FACS
Exploring novel treatment approaches in soft tissue sarcoma

Edward Kim, MD, PhD
Aurora kinase inhibition in pancreatic cancer

Jonathan Riess, MD
Overcoming resistance to epidermal growth factor receptor tyrosine linase inhibitors (EGFR-TKIs) by linking patient derived lung cancer xenotransplants to clinical trials

Thomas Semrad, MD, MAS
Eliminating resistance to anti-vascular endothelial growth factor (VEGF) therapy through translational clinical trials and alternative angiogenic pathways